| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $84.0M | +48.4% |
| Cost of Revenue | $44.0M | +45.2% |
| Gross Profit | $40.1M | +52.1% |
| R&D Expense | $8.0M | +15.7% |
| SG&A Expense | $9.0M | +26.0% |
| Operating Income | $19.6M | +81.7% |
| Interest Expense | $128K | -78.2% |
| Pre-tax Income | -$52K | -111.3% |
| Income Tax | $4.3M |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $29.2M | +50.1% |
| Inventory | $16.2M | +25.6% |
| Current Assets | $57.7M | +44.3% |
| Total Assets | $96.4M | +15.2% |
| Current Liabilities | $11.8M | -9.3% |
| Total Liabilities | $42.9M | +64.4% |
| Stockholders' Equity | $53.5M | -7.1% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.5M | +327.2% |
| Capital Expenditures | $1.6M | +100.7% |
| Investing Cash Flow | -$2.4M | -196.4% |
| Financing Cash Flow | -$826K | -124.4% |
| Free Cash Flow | $5.8M | +242.5% |
| +121.7% |
| Net Income | -$4.3M | -121.5% |
| EPS (Basic) | $0.00 | -100.0% |
| EPS (Diluted) | $0.00 | -100.0% |